Description:

RVNC is the ticker symbol for Revance Therapeutics, Inc., a biotechnology company listed on the New York Stock Exchange (NYSE). Revance Therapeutics focuses on the development and commercialization of innovative neuromodulator products and technologies, particularly in the aesthetic and therapeutic markets. The company's flagship product, DaxibotulinumtoxinA for Injection, commonly known as Dysport in other regions but marketed under the brand name INCOVEZ in the U.S., has been a significant contributor to its portfolio. Additionally, Revance continues to explore advancements in its drug delivery systems and pipeline products aimed at addressing various medical needs beyond aesthetics.

Data:

Yields: